Daily pill doubles survival time in deadliest cancer trial
4 reported
A daily pill can double survival time in patients with the world’s deadliest cancer, according to results of a clinical trial. Experts are calling the treatment a gamechanger and one of the biggest breakthroughs in decades. The drug, daraxonrasib, was discussed by Prof Naureen Starling, a consultant medical oncologist at the Royal Marsden hospital, in an interview with the Guardian. The report is based on a single source and has not been independently verified.
What’s reported
A daily pill can double survival time in patients with the world’s deadliest cancer, according to a clinical trial.
Experts describe the treatment as a gamechanger and one of the biggest breakthroughs in decades.
The drug is called daraxonrasib.
Prof Naureen Starling, consultant medical oncologist at the Royal Marsden hospital, discussed the drug in an interview.
Key figures
Prof Naureen Starling, consultant medical oncologist at the Royal Marsden hospital
Sources: The Guardian
